H

Hospital Sibu | Clinical Research Centre

Research site

(Unclaimed)

Location

Kilometre 9 Jalan Ulu Oya, Sibu, Sarawak, Malaysia

Site insights

Top conditions

Top treatments

Semaglutide

Apixaban

JNJ-64179375

Rilematovir

NNC0519-0130

Seltorexant

AK0529

Pimodivir

Sisunatovir

RO7434656

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 20 total trials

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney funct...

Enrolling

Chronic Kidney Disease

Drug: Placebo

Drug: Semaglutide

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

This study will look at how well CagriSema and cagrilintide help children and adolescents with excess body weight lose weight. The study has 2 parts:...

Begins enrollment this month

Overweight

Obesity

Drug: Placebo cagrilintide

Drug: Cagrilintide

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression (IMAGINATION)

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of sefaxersen (RO7434656), a novel Antisense Oligonucleotide (ASO...

Enrolling

Primary IgA Nephropathy

Drug: Placebo

Drug: Sefaxersen (RO7434656)

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels

This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardiovascular...

Active, not recruiting

Cardiovascular Disease

Drug: Cagrilintide

Drug: Semaglutide